3030, 1490, 1450, 1115 and 1100; δH (400) 1.63–1.67 (2H, m,
5-CH2), 2.62–2.71 (1H, m, 6-H), 2.80–2.85 (1H, m, 1-H), 3.37–
3.44 (1H, m, 4-H), 3.50–3.56 (2H, m, CH2OBn), 3.59 (1H,
app d, J 7.8, 7-Ha), 3.65 (1H, dd, J 12.7 and 3.0, 2-Ha), 3.81
(1H, dd, J 12.7 and 1.0, 2-Hb), 3.98 (1H, d, J 13.3, PhCHaHbN),
4.02 (1H, d, J 13.3, PhCHaHbN), 4.03 (1H, dd, J 7.8 and 5.1,
7-Hb), 4.51 (1H, d, J 12.2, PhCHaHbO), 4.61 (1H, d, J 12.2,
PhCHaHbO) and 7.23–7.40 (10H, m, Ph); δC (100) 29.0 (5-CH2),
40.8 (6-CH), 62.1 (CH2), 62.7 (1-CH), 65.8, 71.0, 73.3, 74.9 (all
CH2), 127.4, 127.6, 127.8, 128.3, 129.4 (all PhCH), 136.8 and
138.2 (both PhC); m/z 339 (Mϩ, 2%), 160 (10), 92 (18) and 91
(100) [Found: Mϩ, 339.1831. C21H25NO3 requires M, 339.1834]
and ii) the (1RS,4SR,6SR)-bicyclo[4.2.1]nonane 36c (58 mg,
16%) as a colourless oil; νmax/cmϪ1 3090, 3060, 3030, 1490, 1450
and 1095; δH (400) 1.44 (1H, ddd, J 14.0, 11.6 and 1.2, 5-Ha),
1.67–1.76 (1H, m, 5-Hb), 2.28–2.34 (2H, m, 9-CH2), 3.64 (1H, d,
J 12.5, 2-Ha), 3.77 (1H, d, J 12.9, PhCHaHbN), 3.84 (1H, dd,
J 12.5 and 5.7, 2-Hb), 3.91–3.98 (1H, m, 1-H), 4.13 (1H, d,
J 12.9, PhCHaHbN), 4.54 (1H, d, J 12.5, PhCHaHbO), 4.58
(1H, d, J 12.5, PhCHaHbO), 4.67–4.71 (1H, m, 6-H) and 7.24–
7.38 (10H, m, Ph); δC (100) 32.3 (5-CH2), 37.3 (9-CH2), 64.1
(CH), 64.3, 73.2, 73.6, 74.8 (all CH2), 75.1 (CH), 76.4 (6-CH),
127.4, 127.5, 127.6, 128.3, 128.4, 129.2 (all PhCH), 137.5 and
138.5 (both PhC); m/z 174 (Mϩ, 4%), 107 (15), 91 (100) and 71
(26).
2.28–2.36 (2H, m, 9-CH2), 3.30–3.36 (1H, m, 1-H), 3.38 (1H,
dd, J 12.0 and 11.0, 4-Ha), 3.56 (1H, d, J 12.6, PhCHaHb), 3.69
(1H, dd, J 12.0 and 4.8, 4-Hb), 3.73 (1H, dd, J 12.8 and 6.2,
2-Ha), 3.75 (1H, d, J 12.8, 2-Hb), 4.41 (1H, ddd, J 4.5, 4.5 and
1.0, 6-H) and 7.24–7.44 (5H, m Ph); δC (100) 13.7 (5-CH3),
32.2 (9-CH2), 39.3 (5-CH), 62.9 (1-CH), 64.0, 72.0, 75.5 (all
CH2), 81.7 (6-CH), 127.4, 128.4, 129.2 (all PhCH) and 137.4
(PhC); m/z 233 (Mϩ, 16%), 160 (28), 91 (100) and 81 (21)
[Found: Mϩ, 233.1411].
(1RS,5SR,6RS)-9-Benzyl-5-phenyl-9-aza-3,8-dioxabicyclo-
[4.3.0]nonane 38e
The ester 31eb (0.60 g) was reduced to the aldehyde 7e directly
using DIBAL-H, exactly as described for the preparation of
aldehyde 7b, method c), and was isolated as a colourless oil
(0.46 g, 90%) and showed νmax/cmϪ1 1737; δH (90) 2.90 (1H, dd,
J 13.7 and 6.7, 4-Ha), 2.95 (1H, dd, J 13.7 and 6.7, 4-Hb), 3.95
(1H, m, 5-H), 4.00 (2H, s, 2-CH2), 5.15 (1H, dd, J 17.1 and 0.7,
7-Ht), 5.20 (1H, dd, J 10.3 and 1.0, 7-Hc), 5.72 (1H, ddd, J 17.1,
10.3 and 8.0, 6-H), 7.20–7.35 (5H, m, Ph) and 9.78 (1H, br s,
CHO); m/z 190 (Mϩ, 6%), 130 (97), 130 (50), 117 (27), 91 (100)
and 77 (23) and was used immediately. Both TLC and 1H NMR
analysis indicated ca. 95% purity.
The foregoing aldehyde 7e (0.46 g) was converted into the
corresponding nitrone 33e as described for the preparation of
nitrone 33b. The crude nitrone 33e was heated in toluene at
60 ЊC for 12 h and the cooled solution evaporated. CC [EtOAc–
petrol (1:4)] of the residue gave the (1RS,5SR,6RS)-bicyclo-
[4.3.0]nonane 38e (350 mg, 46%), Rf 0.36, as a colourless
oil; νmax/cmϪ1 3085, 3061, 3027, 1495, 1454 and 920; δH (400;
CDCl3–C6H6) 2.70 (1H, dd, J 13.8 and 7.2, 4-Ha), 2.84 (1H,
dddd, J 8.8, 6.5, 6.5 and 2.4, 6-H), 2.96 (1H, dd, J 13.8 and 6.5,
4-Hb), 3.35 (1H, dd, J 9.1 and 2.4, 7-Ha), 3.49 (1H, dd, J 9.4 and
6.1, 2-Ha), 3.63 (1H, d, J 12.8, PhCHaHb), 3.68 (1H, ddd, J 8.8,
7.2 and 6.1, 1-H), 3.82 (1H, dd, J 9.1 and 6.5, 7-Hb), 3.85 (1H,
ddd, J 7.2, 6.5 and 6.5, 5-H), 3.99 (1H, dd, J 9.4 and 7.2, 2-Hb)
and 7.09–7.42 (10H, m, Ph); δC (100), 40.6 (4-CH2), 53.9
(6-CH), 60.0 (PhCH2), 69.2 (7-CH2), 71.5 (1-CH), 72.1 (2-CH2),
85.8 (5-CH), 128.5, 128.9, 129.0, 129.2, 129.9, 130.0 (all PhCH),
136.9 and 137.4 (both PhC); m/z 295 (Mϩ, 8%), 204 (14), 174
(81), 148 (32), 106 (30), 91 (100) and 77 (12) [Found: Mϩ,
295.1572. C19H21NO2 requires M, 295.1572].
Also isolated in variable amounts (see discussion) was
(1RS,5SR,6RS)-2-benzyl-4-methyl-5-phenyl-2-aza-3,7-dioxa-
bicyclo[3.3.0]octane 44 as a viscous, colourless oil [Found: C,
77.2; H, 7.5; N, 4.5. C19H21NO2 requires C, 77.3; H, 7.2; N,
4.7%]; νmax/cmϪ1 3090, 3030, 1495, 1454, 1378, 1077 and 1029;
δH (400) 1.41 (3H, d, J 6.3, 4-CH3), 3.70 (1H, m, 1-H), 3.78 (1H,
d, J 9.5, 6-Ha), 3.90–4.10 (2H, m, 8-CH2), 4.00 (1H, d, J 12.8,
PhCHaHb), 4.19 (1H, d, J 12.8, PhCHaHb), 4.28 (1H, d, J 9.5,
6-Hb), 4.72 (1H, q, J 6.3, 4-H) and 7.02–7.41 (10H, m, Ph-H);
δC (100) 12.6 (4-CH3), 59.3 (PhCH2), 62.0 (5-C), 65.6 (8-CH2),
70.8 (6-CH2), 75.8 (1-CH), 78.5 (4-CH), 125.4, 125.8, 126.3,
127.8, 128.2, 128.3 (all PhCH), 135.9 and 141.6 (both PhC); m/z
295 (Mϩ, 15%), 174 (3), 149 (11), 130 (6), 117 (5), 105 (6), 103
(8), 92 (9), 91 (100) and 77 (6).
(1SR,5RS,6SR)- and (1RS,5RS,6RS)-9-Benzyl-5-methyl-9-aza-
3,8-dioxabicyclo[4.3.0]nonane 37d and 38d and (1RS,5RS,6SR)-
8-benzyl-5-methyl-8-aza-3,7-dioxabicyclo[4.2.1]nonane 39d
The 5-methylhept-6-enol 32d (0.22 g) was oxidized using the
Swern method and the resulting aldehyde condensed immedi-
ately with N-benzylhydroxylamine to give the nitrone 33d,
exactly as described for the 4-methyl derivative 33a. The inter-
mediate aldehyde 7d showed δH (90) 1.08 (3H, d, J 7, 5-CH3),
2.46–2.74 (1H, m, 5-H), 3.33–3.75 (2H, m, 4-CH2), 4.15 (2H, s,
2-CH2), 5.00–5.34 (2H, m, 7-CH2), 5.94 (1H, ddd, J 17, 10 and
7, 6-H) and 9.89 (1H, br s, CHO). The nitrone 33d was immedi-
ately dissolved in toluene (10 ml) and the resulting solution
stirred at 80 ЊC for 20 h. The cooled solution was evaporated
and the residue separated by CC [EtOAc–petrol (1:5)] to give i)
the (1RS,5RS,6RS)-bicyclo[4.3.0]nonane 38d (143 mg, 36%), Rf
0.24, as a colourless oil; νmax/cmϪ1 3090, 3060, 3030, 1450 and
1115; δH (400) 0.86 (3H, d, J 6.8, 5-CH3), 1.91–1.99 (1H, m,
5-H), 2.19–2.24 (1H, m, 6-H), 2.85–2.92 (1H, m, 1-H), 3.02 (1H,
dd, J 11.5 and 10.5, 4-Hax), 3.56 (1H, dd, J 12.6 and 3.3, 2-Ha),
3.65 (1H, dd, J 12.6 and 2.4, 2-Hb), 3.69 (1H, dd, J 7.7 and 2.5,
7-Ha), 3.79 (1H, dd, J 11.5 and 4.1, 4-Heq), 3.94 (2H, s, PhCH2),
4.02 (1H, dd, J 7.7 and 6.0, 7-Hb) and 7.21–7.43 (5H, m, PhH);
δC (100) 16.5 (5-CH3), 30.3 (5-CH), 47.4 (6-CH), 61.7 (2-CH2),
62.4 (1-CH), 66.1 (PhCH2), 69.3, 71.6 (both CH2), 127.2, 128.2,
129.1 (all PhCH) and 137.1 (PhC); m/z 233 (Mϩ, 36%), 188
(24), 161 (12), 92 (13) and 91 (100) [Found: Mϩ, 233.1423.
C14H19NO2 requires M, 233.1416], ii) the (1SR,5RS,6SR)-
bicyclo[4.3.0]nonane 37d (33 mg, 9%), Rf 0.29, as a colourless
oil; νmax/cmϪ1 3090, 3070, 3040, 1490, 1455 and 1105; δH (400)
0.89 (3H, d, J 7.1, 5-CH3), 2.17–2.25 (1H, m, 5-H), 3.07–
3.21 (1H, m, 6-H), 3.15 (1H, dd, J 11.5 and 11.5, 4-Hax),
3.19 (1H, dd, J 11.3 and 11.3, 2-Hax), 3.31 (1H, ddd, J 11.3,
6.2 and 6.2, 1-H), 3.64 (1H, dd, J 11.5 and 5.0, 4-Heq), 3.77
(1H, d, J 12.6, PhCHaHb), 3.80 (1H, dd, J 11.3 and 6.2, 2-Heq),
3.86 (1H, dd, J 9.8 and 7.7, 7-Ha), 4.07 (1H, d, J 12.6,
PhCHaHb), 4.17 (1H, dd, J 9.8 and 7.9, 7-Hb) and 7.25–7.38
(5H, m, Ph); δC (100) 15.4 (5-CH3), 29.5 (5-CH), 42.6 (6-CH),
60.0 (1-CH), 60.7, 65.7, 66.8, 68.7 (all CH2), 127.5, 128.5, 129.0
(all PhCH) and 137.2 (PhC); m/z 233 (Mϩ, 54%), 188 (44), 161
(15), 92 (18) and 91 (100) [Found: Mϩ, 233.1414] and iii) the
(1RS,5RS,6SR)-bicyclo[4.2.1]nonane 39d (36 mg, 10%), Rf, as
a colourless oil; νmax/cmϪ1 3090, 3070, 3040, 1490 and 1455;
δH (400) 0.87 (3H, d, J 7.1, 5-CH3), 1.70–1.79 (1H, m, 5-H),
(1RS,5RS,6RS)-9-Benzyl-5-(tert-butyldimethylsilyloxymethyl)-
9-aza-3,8-dioxabicyclo[4.3.0]nonane 38f
The ester 31fb was reduced to the aldehyde 7f directly using
DIBAL-H, exactly as described for the preparation of aldehyde
7b, method c), and was isolated as a colourless oil (90–93%);
νmax/cmϪ1 1740 and 1640; δH (250) 0.00 (6H, s, 2 × SiCH3), 0.84
(9H, s, SiC(CH3)3), 2.47 (1H, m, 5-H), 3.40–3.65 (6H, m, 2- and
4-CH2 and CH2Si), 5.09 (1H, dd, J 11.6 and 1.2, 7-Hc), 5.13 (1H,
dd, J 17.4 and 1.2, 7-Ht), 5.75 (1H, ddd, J 17.4, 11.6 and 7.9,
6-H) and 9.70 (1H, t, J 0.9, CHO) and was used immediately
1
as it proved to be rather sensitive. Both TLC and H NMR
analysis indicated ca. 95% purity.
J. Chem. Soc., Perkin Trans. 1, 1999, 3143–3155
3153